Coronary Microvascular Function Assessment using the Coronary Angiography-Derived Index of Microcirculatory

Ming Li1, Xi Peng1, Naixin Zheng1

  • 1Department of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, 100730 Beijing, China.

Insights

Coronary microvascular dysfunction is common in ST-segment elevation myocardial infarction (STEMI) patients after primary percutaneous coronary intervention (PCI). An elevated coronary angiography-derived index of microcirculatory resistance (caIMR) predicts major adverse cardiovascular events.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Coronary microvascular function assessment post-primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) is limited.
  • Coronary angiography-derived index of microcirculatory resistance (caIMR) offers a method to evaluate microvascular function in the infarct-related artery (IRA).

Purpose of the Study:

  • To assess coronary microvascular function using caIMR in STEMI patients undergoing primary PCI.
  • To determine the association between caIMR and major adverse cardiovascular events (MACE) post-primary PCI.

Main Methods:

  • The FlashAngio system was used to measure caIMR in 157 STEMI patients post-primary PCI.
  • MACE was defined as a composite of cardiac mortality, target vessel revascularization, and rehospitalization for heart failure, myocardial infarction, or angina.

Main Results:

  • Approximately 30% of STEMI patients with successful primary PCI had an IRA caIMR < 40.
  • IRA caIMR was significantly higher than reference vessel caIMR (p < 0.001).
  • An IRA caIMR ≥ 40 was associated with higher 3-month and 1-year MACE rates, primarily driven by rehospitalizations for heart failure, myocardial infarction, or angina.

Conclusions:

  • STEMI patients frequently exhibit coronary microvascular dysfunction after primary PCI, indicated by elevated IRA caIMR.
  • An IRA caIMR ≥ 40 independently predicts MACE at 3 months and 1 year in STEMI patients post-primary PCI.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...